WEBSITE BSE:501261 NSE: LORDSMARK Inc. Year: 1979 Industry: Finance - NBFC My Bucket: Add Stock
Last updated: 00:00
No Notes Added Yet
1. Business Overview
Lords Mark Industries Ltd. is a diversified entity with a significant Non-Banking Financial Company (NBFC) arm, holding an RBI registration as a Non-Deposit Taking NBFC. While primarily categorized under Finance - NBFC, its operations span multiple sectors. Its core financial services segment provides supply chain finance (including invoice discounting, bill discounting, and vendor financing) primarily to Micro, Small, and Medium Enterprises (MSMEs) across various sectors such as healthcare, infrastructure, electric vehicles, and hospitality. Additionally, it offers short-term loans, working capital loans, and term loans. Beyond financial services, Lords Mark Industries is actively involved in the manufacturing and trading of healthcare products (like rapid diagnostic kits and medical devices), providing digital marketing services, and developing EV charging infrastructure and battery swapping solutions. The NBFC arm aims to leverage its understanding of these key sectors to provide specialized financing solutions.
2. Key Segments / Revenue Mix
While precise revenue contribution percentages from each segment are not readily available for this newly listed entity, Lords Mark Industries' operations can be broadly segmented as follows:
Financial Services: This segment focuses on lending, including supply chain finance (invoice discounting, bill discounting, vendor financing) and other loans (short-term, working capital, term loans). These services are strategically focused on sectors like healthcare, infrastructure, electric vehicles, and hospitality.
Healthcare Solutions: Manufacturing and trading of diagnostic kits, medical devices, and other healthcare products, often under its own brands like LordsMed.
Electric Vehicle (EV) Infrastructure: Development and operation of EV charging stations and battery swapping solutions.
Digital Marketing Services: Providing various digital marketing solutions to clients.
The financial services arm generates revenue primarily through interest income on loans and fees for financial services, while other segments generate revenue through product sales or service fees.
3. Industry & Positioning
The Indian NBFC sector is highly competitive, comprising a wide array of players from large, diversified entities to niche, specialized lenders, alongside dominant public and private sector banks. Lords Mark Industries positions itself as a diversified player with a specialized lending focus within its NBFC arm, targeting the MSME segment in specific high-growth sectors like healthcare and EVs. As a relatively smaller, non-deposit-taking NBFC, it operates in a competitive landscape where larger banks and NBFCs often have greater access to cheaper funds and wider distribution networks. Its multi-business approach attempts to create synergies, with the financial services arm potentially supporting or benefiting from its other ventures. It primarily competes with other small to mid-sized NBFCs and fintech lenders specializing in MSME and supply chain finance.
4. Competitive Advantage (Moat)
Lords Mark Industries' competitive advantages are likely in development given its relatively nascent stage as a publicly listed entity with a diversified business model. Potential advantages include:
Sectoral Specialization: Its combined presence in healthcare and EV sectors, alongside its financial services, could provide domain expertise and relationship-based lending advantages to MSMEs within these niches, potentially leading to better underwriting and deal sourcing.
Synergistic Business Model: The ability to potentially cross-sell financial services to its healthcare product clients or EV infrastructure partners could create captive demand and reduce customer acquisition costs.
Agility & Niche Focus: As a smaller, non-deposit-taking NBFC, it may possess greater agility to cater to specific MSME financing needs that larger banks or NBFCs might overlook due to stringent norms or focus on larger ticket sizes.
However, established moats like broad brand recognition, vast scale, or significantly lower cost of funds are not yet apparent.
5. Growth Drivers
Growing MSME Credit Demand: India's large and underserved MSME sector continues to drive demand for formal credit, especially for working capital and supply chain financing.
Expansion in Niche Sectors: Increasing demand for healthcare products and services, coupled with the rapid growth of the EV ecosystem in India, provides significant opportunities for specialized financing and related product/service offerings.
Digitalization & Fintech Integration: Leveraging technology for faster loan processing, better risk assessment, and wider reach to MSMEs can drive efficiency and growth.
Cross-Selling Opportunities: Synergy between its financial services, healthcare, and EV businesses could lead to cross-selling and up-selling opportunities, expanding its customer base and revenue per customer.
Geographic Expansion: Extending its lending and other business operations to new geographies within India could unlock further growth.
6. Risks
Credit Risk: The primary risk for any lending business, particularly in the MSME segment, involves potential defaults or delays in repayment, impacting asset quality and profitability.
Liquidity and Funding Risk: As a non-deposit-taking NBFC, reliance on wholesale funding, bank lines, or debt markets exposes it to interest rate fluctuations and challenges in raising funds, especially during tight liquidity conditions.
Regulatory & Compliance Risk: Changes in RBI regulations, capital adequacy norms, or other financial sector policies can significantly impact operations and profitability.
Competitive Pressure: Intense competition from established banks, large NBFCs, and emerging fintech lenders in the MSME and supply chain finance space can compress margins.
Diversification Risk: Managing a portfolio of diverse businesses (finance, healthcare, EV, digital marketing) requires varied expertise and resources, potentially leading to operational complexities and diluted focus if not managed effectively.
Sector-Specific Risks: The healthcare product business faces competition and regulatory hurdles, while the EV infrastructure business depends on EV adoption rates and government policies.
7. Management & Ownership
Lords Mark Industries Ltd. is promoted by Mr. Sachidanand Roy, who serves as the Chairman and Managing Director. The management team consists of experienced professionals across its various business verticals. As a newly listed company on NSE Emerge, promoter holding is typically significant, ensuring alignment of interests. The overall management quality and depth will be crucial for navigating its diverse business ventures and executing its growth strategies. Details on the broader board and key management personnel would be available in its public filings.
8. Outlook
Lords Mark Industries presents an interesting profile with its diversified business model centered around financial services and strategic investments in high-growth sectors like healthcare and electric vehicles. The demand for MSME credit in India remains robust, offering a strong tailwind for its NBFC arm. Its sectoral specialization and potential synergies between its different businesses could provide unique growth avenues and customer acquisition strategies. However, the company faces inherent risks associated with its diversified nature, including execution challenges across multiple business lines, significant competitive pressures in both lending and its other verticals, and the typical credit and liquidity risks inherent to the NBFC sector. Its ability to effectively manage asset quality, raise funds efficiently, and successfully integrate and scale its diverse operations will be critical for long-term sustainable growth and profitability. The outlook depends heavily on the disciplined execution of its strategy across all segments and its capacity to build a defensible niche in its chosen markets.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹70 Cr.
Stock P/E -10.4
P/B -28.2
Current Price ₹703.2
Book Value ₹ -25
Face Value 10
52W High ₹669.7
Dividend Yield 0%
52W Low ₹ 0
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Provision for Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjustments | -0 | 0 | 0 | 0 | 0 | -0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Adjusted Earnings Per Share | -0.2 | -0.5 | -0.3 | -1.4 | -3.1 | -0.4 | -4.7 | -0.5 | -0.4 | -0.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 4 | 5 | 4 | 3 | 6 | 6 | 2 | 1 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 4 | 5 | 4 | 4 | 6 | 6 | 2 | 1 | 0 | 0 | 0 | 0 |
| Total Expenditure | 4 | 5 | 4 | 3 | 5 | 6 | 1 | 1 | 0 | 0 | 1 | 0 |
| Operating Profit | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | -0 | -0 | -1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | -0 | -1 | -7 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Tax | 0 | -0 | 0 | 1 | 1 | -0 | 0 | 0 | -0 | -1 | -7 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | -0 | 0 | 1 | 1 | -0 | 0 | 0 | -0 | -1 | -7 | 0 |
| Adjusted Earnings Per Share | 0.5 | -0.5 | 2.5 | 7.8 | 9.1 | -0.5 | 3.5 | 0.4 | -1.6 | -9.5 | -67.3 | -5.9 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | -100% | -100% | -100% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 63% | 34% | 20% | 13% |
| ROE Average | -747% | -257% | -152% | -65% |
| ROCE Average | -157% | -56% | -32% | -10% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 5 | 5 | 4 | -2 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Total Current Liabilities | 3 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 7 |
| Total Liabilities | 7 | 7 | 6 | 6 | 8 | 5 | 6 | 5 | 6 | 6 | 5 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4 | 5 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 1 |
| Total Current Assets | 3 | 2 | 3 | 3 | 4 | 2 | 3 | 3 | 4 | 4 | 4 |
| Total Assets | 7 | 7 | 6 | 6 | 8 | 5 | 6 | 5 | 6 | 6 | 5 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Cash Flow from Operating Activities | 0 | 1 | 0 | -2 | 1 | -2 | 1 | -0 | -1 | 0 | -4 |
| Cash Flow from Investing Activities | -0 | -1 | -0 | -0 | -1 | 3 | -0 | -0 | 0 | 0 | 0 |
| Cash Flow from Financing Activities | -0 | -0 | -0 | 2 | 0 | -2 | -0 | 0 | 1 | 0 | 4 |
| Net Cash Inflow / Outflow | -0 | 0 | 0 | -0 | 0 | -0 | 1 | -0 | -0 | 0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.47 | -0.46 | 2.45 | 7.77 | 9.12 | -0.47 | 3.47 | 0.44 | -1.6 | -9.5 | -67.29 |
| CEPS(Rs) | 0.85 | -0.2 | 2.47 | 7.79 | 9.22 | -0.31 | 3.64 | 0.56 | -1.5 | -9.41 | -67.21 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 30.39 | 29.93 | 33.42 | 41.19 | 50.31 | 49.84 | 53.31 | 53.75 | 52.16 | 42.66 | -24.63 |
| Core EBITDA Margin(%) | 3.34 | 1.64 | 1.84 | -3.32 | 16.46 | -8.66 | 24.87 | -0.67 | -142.59 | 0 | 0 |
| EBIT Margin(%) | 2.68 | 1.12 | 9.9 | 29.1 | 20.11 | 0.8 | 24.57 | 7.2 | -142.65 | 0 | 0 |
| Pre Tax Margin(%) | 1.9 | 1.09 | 9.9 | 29.1 | 20.11 | 0.8 | 24.57 | 7.2 | -142.65 | 0 | 0 |
| PAT Margin (%) | 1.17 | -0.95 | 6.81 | 23.24 | 15.13 | -0.86 | 18.06 | 4.76 | -140.01 | 0 | 0 |
| Cash Profit Margin (%) | 2.1 | -0.43 | 6.87 | 23.32 | 15.31 | -0.56 | 18.9 | 6.03 | -131.59 | 0 | 0 |
| ROA(%) | 0.69 | -0.65 | 3.66 | 12.92 | 13.41 | -0.73 | 6.16 | 0.79 | -2.69 | -14.73 | -121.8 |
| ROE(%) | 1.57 | -1.51 | 7.74 | 20.82 | 19.94 | -0.94 | 6.74 | 0.82 | -3.01 | -20.04 | -746.6 |
| ROCE(%) | 3.11 | 1.6 | 10.22 | 19.84 | 18.17 | 0.71 | 8.97 | 1.25 | -2.76 | -8.49 | -157.17 |
| Receivable days | 0.11 | 0 | 0 | 0 | 0.44 | 22.44 | 0 | 21.21 | 0 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 1445.87 | 1343.2 | 0 | 0 | 18.67 | 37.25 | 376.29 | 1263.11 | 0 | 0 | 0 |
| PER(x) | 451.37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 7.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.6 | -16.7 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 5.33 | 0.24 | 0.1 | 0.62 | 0.35 | 0.22 | 0.25 | 0.94 | 19.08 | 0 | 0 |
| EV/Core EBITDA(x) | 147.72 | 14.5 | 0.97 | 2.12 | 1.73 | 20.13 | 0.99 | 11.08 | -14.22 | -67.74 | -50.31 |
| Net Sales Growth(%) | 63.67 | 18.19 | -24.93 | -7.15 | 80.31 | -8.54 | -65.11 | -51.78 | -87.71 | -100 | 0 |
| EBIT Growth(%) | 17.2 | -50.75 | 566.48 | 172.83 | 24.58 | -96.36 | 970.87 | -85.88 | -343.69 | -210.19 | -1229.26 |
| PAT Growth(%) | 13.54 | -196.36 | 637.73 | 216.98 | 17.41 | -105.18 | 835.71 | -87.3 | -461.7 | -495.26 | -608.26 |
| EPS Growth(%) | 13.55 | -196.36 | 637.69 | 216.98 | 17.41 | -105.18 | 835.64 | -87.3 | -461.68 | -495.24 | -608.26 |
| Debt/Equity(x) | 0.13 | 0.09 | 0.11 | 0.48 | 0.44 | 0.05 | 0 | 0 | 0.23 | 0.28 | -2.25 |
| Current Ratio(x) | 0.78 | 0.53 | 1.25 | 86.77 | 14.68 | 7.88 | 5.78 | 38.7 | 3.04 | 1.7 | 0.54 |
| Quick Ratio(x) | 0.78 | 0.53 | 1.25 | 86.77 | 14.68 | 7.88 | 5.78 | 38.7 | 3.04 | 1.7 | 0.54 |
| Interest Cover(x) | 3.44 | 49.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.13 | -314.74 |
| Total Debt/Mcap(x) | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.13 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 49.01 | 49.01 | 49.01 | 49.01 | 49.01 | 49.01 | 49.01 | 49.01 | 49.01 | 80.84 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 50.99 | 50.99 | 50.99 | 50.99 | 50.99 | 50.99 | 50.99 | 50.99 | 50.99 | 19.16 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 34.49 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 8.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 42.66 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.